This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PCMA Recruits Wendy Krasner As New Vice President Of Regulatory Affairs

WASHINGTON, Feb. 28, 2013 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) today announced the appointment of Wendy Krasner as the association's new Vice President of Regulatory Affairs.

One of Washington's preeminent health care regulatory experts, Ms. Krasner brings over 30 years of experience to PCMA, including working on issues involving Medicare, Medicaid, and the Affordable Care Act (ACA).  Ms. Krasner comes to PCMA from Manatt, Phelps & Phillips LLP, where she has been a partner within the health care practice.  Prior to joining Manatt, Ms. Krasner served as Deputy Vice President for Policy at the Pharmaceutical Research and Manufacturers of America (PhRMA) and was a partner in the Washington, D.C., office of McDermott Will & Emery.



"Wendy is widely known as one of America's premier health care regulatory experts.  We're proud to have her on the team," said PCMA President and CEO Mark Merritt.

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 215 million Americans.

Follow PCMA on Twitter

SOURCE Pharmaceutical Care Management Association

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs